Opportunity ID: 279538

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-364
Funding Opportunity Title: Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Oct 06, 2015
Last Updated Date: Nov 22, 2017
Original Closing Date for Applications: Sep 07, 2018
Current Closing Date for Applications: Jan 24, 2018
Archive Date: Feb 23, 2018
Estimated Total Program Funding: $25,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Small businesses
Independent school districts
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-364.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
This FOA has been reissued and will close on January 24, 2018. Applicants must use reissued FOA with FORMS-E application forms for due dates on or after January 25, 2018 Nov 22, 2017
Nov 22, 2017

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-364
Funding Opportunity Title: Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Oct 06, 2015
Last Updated Date: Nov 22, 2017
Original Closing Date for Applications: Sep 07, 2018
Current Closing Date for Applications: Jan 24, 2018
Archive Date: Feb 23, 2018
Estimated Total Program Funding: $25,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Small businesses
Independent school districts
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-364.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-364
Funding Opportunity Title: Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 22, 2017
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Sep 07, 2018
Archive Date: Oct 08, 2018
Estimated Total Program Funding: $25,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Special district governments
Independent school districts
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
State governments
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-364.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00219073 Nov 11, 2015 Mar 31, 2016 View
FORMS-D Use for due dates on or before January 24, 2018 PKG00222153 May 05, 2016 Jan 24, 2018 View

Package 1

Mandatory forms

279538 RR_SF424_2_0-2.0.pdf

279538 PHS398_ResearchPlan_2_0-2.0.pdf

279538 PHS398_CoverPageSupplement_2_0-2.0.pdf

279538 RR_KeyPersonExpanded_2_0-2.0.pdf

279538 RR_OtherProjectInfo_1_3-1.3.pdf

279538 PerformanceSite_2_0-2.0.pdf

Optional forms

279538 RR_SubawardBudget30_1_3-1.3.pdf

279538 PlannedReport-1.0.pdf

279538 PHS398_CumulativeInclusionReport-1.0.pdf

279538 PHS398_ModularBudget_1_2-1.2.pdf

279538 RR_Budget_1_3-1.3.pdf

Package 2

Mandatory forms

279538 RR_SF424_2_0-2.0.pdf

279538 PHS398_CoverPageSupplement_3_0-3.0.pdf

279538 RR_OtherProjectInfo_1_3-1.3.pdf

279538 PerformanceSite_2_0-2.0.pdf

279538 RR_KeyPersonExpanded_2_0-2.0.pdf

279538 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

279538 RR_Budget_1_3-1.3.pdf

279538 RR_SubawardBudget30_1_3-1.3.pdf

279538 PHS398_ModularBudget_1_2-1.2.pdf

279538 PHS_Inclusion_Enrollment_Report-1.0.pdf

279538 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T17:34:10-05:00

Share This Post, Choose Your Platform!

About the Author: